Viridian Therapeutics, Inc

At Viridian Therapeutics, we are focused on developing best-in-class medicines for people living with autoimmune and rare diseases. Leveraging our team’s expertise in antibody discovery and engineering, we have created a robust pipeline of differentiated investigational therapeutic candidates for well-validated targets. Our unique approach to innovation allows us to allocate our research and development resources strategically to address high unmet medical needs, designing therapeutics that aim to provide differentiated clinical activity, improved safety and tolerability, and convenient delivery and administration for patients.

Our thyroid eye disease program exemplifies our drug development strategy in action, as we aim to improve upon the standard-of-care and currently available treatment options within commercially established disease areas, with the ultimate goal of elevating patients’ lives. Founded with a mission to significantly enhance treatment options for autoimmune and rare diseases, we hope to provide effective, safe, and easy-to-use therapies for individuals living with thyroid eye disease and other conditions. Thus, allowing them to lead fulfilling, healthy lives.